Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Sharanya Sarkar"'
Autor:
Lily Taub, Thomas H. Hampton, Sharanya Sarkar, Georgia Doing, Samuel L. Neff, Carson E. Finger, Kiyoshi Ferreira Fukutani, Bruce A. Stanton
Publikováno v:
mSystems, Vol 9, Iss 11 (2024)
ABSTRACT E.PathDash facilitates re-analysis of gene expression data from pathogens clinically relevant to chronic respiratory diseases, including a total of 48 studies, 548 samples, and 404 unique treatment comparisons. The application enables users
Externí odkaz:
https://doaj.org/article/4df9b5f32c51460eb0fa75aea18e143a
Autor:
Samuel L. Neff, Thomas H. Hampton, Katja Koeppen, Sharanya Sarkar, Casey J. Latario, Benjamin D. Ross, Bruce A. Stanton
Publikováno v:
mSystems, Vol 8, Iss 6 (2023)
ABSTRACT Developing software tools that leverage biological data sets to accelerate drug discovery is an important aspect of bioinformatic research. Here, we present a novel example: a web application called Rocket-miR that applies an existing bioinf
Externí odkaz:
https://doaj.org/article/38af883ac4f94636bc3aa24c3f8bf9e5
Autor:
Shiwei Xu, Margaret C. Carpenter, Rachel L. Spreng, Scott D. Neidich, Sharanya Sarkar, DeAnna Tenney, Derrick Goodman, Sheetal Sawant, Shalini Jha, Brooke Dunn, M. Juliana McElrath, Valerie Bekker, Sarah V. Mudrak, Robin Flinko, George K. Lewis, Guido Ferrari, Georgia D. Tomaras, Xiaoying Shen, Margaret E. Ackerman
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-14 (2022)
Abstract Adjuvants can alter the magnitude, characteristics, and persistence of the humoral response to protein vaccination. HIV vaccination might benefit from tailored adjuvant choice as raising a durable and protective response to vaccination has b
Externí odkaz:
https://doaj.org/article/9ea7f299da3f47918d880c37d8b44de9
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy
Autor:
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Shruthi Mangalaganesh, Ryan P. Nolan, Dean Bottino, Greg Hather, Natasha S. Hochberg, Laura F. White, Arijit Chakravarty
Publikováno v:
Vaccines, Vol 11, Iss 4, p 806 (2023)
SARS-CoV-2 vaccinations were initially shown to substantially reduce risk of severe disease and death. However, pharmacokinetic (PK) waning and rapid viral evolution degrade neutralizing antibody (nAb) binding titers, causing loss of vaccinal protect
Externí odkaz:
https://doaj.org/article/96a245fc87ee4429b1fd2755184c4612
Autor:
Vipul Swarup Bhatnagar, Prasun Bandyopadhyay, Girish H. Rajacharya, Sharanya Sarkar, Krishna Mohan Poluri, Shashi Kumar
Publikováno v:
Biotechnology for Biofuels, Vol 12, Iss 1, Pp 1-19 (2019)
Abstract Background Many studies have been carried out on the growth-modulating efficiency of plants by the colonization of an endophytic fungus Piriformospora indica. However, studies involving the co-culture of alga with endophytic fungal strains f
Externí odkaz:
https://doaj.org/article/987be4d095c442fea32371992b48efa5
Autor:
Madison Stoddard, Sharanya Sarkar, Lin Yuan, Ryan P Nolan, Douglas E White, Laura F White, Natasha S Hochberg, Arijit Chakravarty
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254734 (2021)
As the COVID-19 pandemic drags into its second year, there is hope on the horizon, in the form of SARS-CoV-2 vaccines which promise disease suppression and a return to pre-pandemic normalcy. In this study we critically examine the basis for that hope
Externí odkaz:
https://doaj.org/article/157bb18bb79f479e8c89f81e55ead2f8
Autor:
Madison Stoddard, Alexander Novokhodko, Sharanya Sarkar, Debra Van Egeren, Laura F. White, Natasha S. Hochberg, Michael S. Rogers, Bruce Zetter, Diane Joseph-McCarthy, Arijit Chakravarty
Publikováno v:
COVID; Volume 2; Issue 12; Pages: 1689-1709
We have entered a new phase of the ongoing COVID-19 pandemic, as the strategy of relying solely on the current SARS-CoV-2 vaccines to bring the pandemic to an end has become infeasible. In response, public-health authorities in many countries have ad
The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2
Autor:
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Debra Van Egeren, Laura F. White, Arijit Chakravarty
In the fourth year of the COVID-19 pandemic, public health authorities worldwide have adopted a strategy of learning to live with SARS-CoV-2. This has involved the removal of measures for limiting viral spread, resulting in a large burden of recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a310055b54cd478239e5fe486d746ca2
https://doi.org/10.1101/2023.02.26.23286471
https://doi.org/10.1101/2023.02.26.23286471
Autor:
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Debra van Egeren, Shruthi Mangalaganesh, Ryan P. Nolan, Michael S. Rogers, Greg Hather, Laura F. White, Arijit Chakravarty
While the rapid deployment of SARS-CoV-2 vaccines had a significant impact on the ongoing COVID-19 pandemic, rapid viral immune evasion and waning neutralizing antibody titers have degraded vaccine efficacy. Nevertheless, vaccine manufacturers and pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27119959b78c6afd40ea04630809b383
https://doi.org/10.1101/2023.01.26.23285076
https://doi.org/10.1101/2023.01.26.23285076
Autor:
Madison Stoddard, Lin Yuan, Sharanya Sarkar, Matthew Mazewski, Debra van Egeren, Shruthi Mangalaganesh, Ryan P. Nolan, Michael S. Rogers, Greg Hather, Laura F. White, Arijit Chakravarty
As the COVID-19 pandemic continues unabated, many governments and public-health bodies worldwide have ceased to implement concerted measures for limiting viral spread, placing the onus instead on the individual. In this paper, we examine the feasibil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16083706187d5c29154d555ea7badbba
https://doi.org/10.1101/2023.01.22.23284884
https://doi.org/10.1101/2023.01.22.23284884